Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
7
×
life sciences
national blog main
new york blog main
new york top stories
7
×
biotech
national top stories
boston top stories
clinical trials
san francisco blog main
novartis
san francisco top stories
sanofi
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
new york
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
amgen
biogen
deals
deerfield management
What
medicines
7
×
drug
fda
ipo
new
announced
bio
covid
deal
roundup
acquire
acquisitions
activity
agreed
amgen
approval
approvals
backs
bets
billion
biogen
biotechs
brings
candidates
cash
central
ceo
cholesterol
clamped
class
click
cns
collabs
company
company’s
compound
course
daniel
delays
developed
Language
unset
Current search:
fda
×
" new york top stories "
×
medicines
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines